Bentley Pharmaceuticals Announces Extension of Its Research Collaboration With Pfizer.Business Editors & Health/Medical Writers NORTH HAMPTON North Hampton is the name of several places in the United States:
Bentley Pharmaceuticals, Inc. (AMEX AMEX See: American Stock Exchange : BNT BNT Bentley Pharmaceuticals, Inc. (stock symbol) BNT Boston Naming Test (psychology) BNT Bermuda National Trust BNT Bulgarian National TV BNT Broadband Network Termination BNT Binary File Transfer ) announced today that it has extended its R&D collaborative agreement with Pfizer Inc (NYSE NYSE See: New York Stock Exchange : PFE 1. (text, editor) PFE - Programmer's File Editor. 2. (language) PFE - Portable Forth Environment. ). Under the terms of the agreement, Bentley and Pfizer will continue to evaluate certain Pfizer compounds for enhanced delivery. As part of the agreement, Pfizer has access to Bentley's drug delivery platform through a research license. Pfizer will continue to provide the funding necessary to enhance its compounds in formulations that include Bentley's patented drug-delivery technology. Commenting on the collaboration, James R. Murphy, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Bentley, said, "We are pleased to expand our collaboration with Pfizer, which is known for its commitment to and strong investment in R&D. We are confident that Bentley's technology will continue to demonstrate impressive enhancement that improves absorption and utilization of proprietary drugs." Murphy continued, "We look forward to providing Pfizer continued access to our proprietary drug delivery technology, recognizing that Pfizer is among the world's leading pharmaceutical companies." Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and pharmaceutical products. Bentley's proprietary drug technologies enhance or facilitate the absorption of pharmaceutical compounds across various membranes. Bentley also manufactures and markets a growing portfolio of generic and branded pharmaceuticals in Spain for the treatment of cardiovascular, gastrointestinal, infectious and neurological diseases through its subsidiaries Laboratorios Belmac and Laboratorios Davur. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with identifying suitable drugs for drug delivery technologies, expanding generic and branded drug operations, development and commercialization of our products, relationships with our strategic partners, uncertainty of clinical trials, regulatory approval process, product sales concentration, unpredictability of patent protection, technological changes, the effect of economic conditions and other uncertainties detailed in Bentley's filings with the Securities and Exchange Commission. Copies of the Company's press releases and other information may be obtained through Bentley's web site at www.bentleypharm.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion